Oncology & Cancer

Consumer health: Treating bladder cancer

More than 81,000 new cases of bladder cancer will be diagnosed in the U.S. in 2022, and more than 17,000 people will die of the disease, according to the American Cancer Society.

Oncology & Cancer

Cancer immunotherapy capable of modulating tumor immunophenotypes

Innovations in cancer immunotherapy have achieved clinical success by considerably increasing the survival rate of patients undergoing cancer treatment. However, there still exists an unmet medical need due to the low response ...

Oncology & Cancer

Discovery could lead to better cancer immunotherapy

A type of white blood cell previously known only as a helper in the immune system appears also to be the instigator of the body's defenses against cancerous tumors. The discovery could lead to more effective cancer immunotherapy, ...

Oncology & Cancer

Desmoplastic melanoma responds to PD-1 blockade immunotherapy

Tumors from desmoplastic melanoma, a rare cancer most commonly found on the head or neck, can often be shrunk significantly before surgery by an immunotherapy known as PD-1 blockade, a result that may reduce the need for ...

Oncology & Cancer

Consumer Health: What do you know about testicular cancer?

April is Testicular Cancer Awareness Month, which makes this a good time to learn about testicular cancer. Compared with other types of cancer, testicular cancer is rare. But testicular cancer is the most common cancer in ...

page 17 from 40